List of high-quality authors
Maipu Medical: Director Yuan Meifu plans to increase his holdings of 1 million yuan to 2 million yuan of the company's shares
Maipu Medical announced that Mr. Yuan Meifu, a shareholder and director of the company holding more than 5% of the company's shares, increased his holdings of 300 shares of the company through centralized bidding through the Shenzhen ** Exchange system on February 8, 2024, accounting for 00005%, and the amount of increased holdings was 8,019 yuan. Within 6 months from February 8, 2024, the date of the first increase in shareholdings, Mr. Yuan Meifu intends to continue to increase his shareholding in the Company with an amount of not less than RMB1 million and no more than RMB2 million (both inclusive, including the amount of the first increase in shares of RMB8,019).
Aerospace Technology: Net profit in 2023 will increase by 1% year-on-year15%】
Aerospace Technology announced its 2023 annual performance report, and during the reporting period, the company achieved operating income of 210,384820,000 yuan, an increase of 44 over the same period last year69%；Net profit attributable to owners of the parent company was 18,549440,000 yuan, an increase of 1 over the same period last year15%。
Kelong shares: directors and executives plan to increase their holdings of 100,000-200,000 yuan in the company's shares
Kelong shares announced that Mr. Zhou Quankai, director and senior management of the company, based on the confidence in the company's sustainable and stable development in the future and the recognition of long-term investment value, Mr. Zhou Quankai plans to increase his holdings of the company's shares through the Shenzhen ** Exchange system in a centralized bidding transaction within six months from the date of disclosure of the announcement, with a total amount of not less than RMB 100,000 and no more than RMB 200,000. The shareholding increase plan does not set the first range, and the subject of the increase will be based on the reasonable judgment of the company's value, combined with the company's volatility and the overall trend of the capital market, and choose the opportunity to implement the increase during the increase plan.
Yirui Biotech: 2The 7.3 billion pre-IPO issued shares will be lifted on February 20
Yirui Biotech announced the indicative announcement of the listing and circulation of the issued shares before the initial public offering, and the restricted shares listed and circulated this time are the issued shares of the company before the initial public offering, and the number of shares released from the restricted sale is 27.3 billion shares, accounting for 68.8 percent of the company's total share capital18%。The lock-up period is 36 months from the date of listing. The listing and circulation date of the shares released this time is February 20, 2024 (Tuesday).